{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:58:43Z","timestamp":1777859923360,"version":"3.51.4"},"reference-count":13,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Renin Angiotensin Aldosterone Syst"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1177\/1470320320926902","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T01:42:34Z","timestamp":1589420554000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["COVID-19: The race for a vaccine"],"prefix":"10.1177","volume":"21","author":[{"given":"Emily","family":"Lockey","sequence":"first","affiliation":[{"name":"Fieldfisher LLP, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"key":"bibr1-1470320320926902","unstructured":"World Health Organization. DRAFT landscape of COVID-19 candidate vaccines, www.who.int\/blueprint\/priority-diseases\/key-action\/novel-coronavirus-landscape-ncov (accessed 11 April 2020)."},{"key":"bibr2-1470320320926902","unstructured":"Virological. Novel 2019 coronavirus genome, http:\/\/virological.org\/t\/novel-2019-coronavirus-genome\/319 (accessed 6 May 2020)."},{"key":"bibr3-1470320320926902","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2008-3"},{"key":"bibr4-1470320320926902","unstructured":"Imperial College London. Imperial researchers in race to develop coronavirus vaccine, www.imperial.ac.uk\/news\/195055\/imperial-researchers-race-develop-coronavirus-vaccine\/ (accessed XXX)."},{"key":"bibr5-1470320320926902","unstructured":"University of Oxford. Oxford COVID-19 vaccine begins human trial stage, www.ox.ac.uk\/news\/2020-04-23-oxford-covid-19-vaccine-begins-human-trial-stage (accessed 06 May 2020)."},{"key":"bibr6-1470320320926902","unstructured":"Oxford Vaccine Group. COVID-19 vaccine development, https:\/\/www.ovg.ox.ac.uk\/news\/covid-19-vaccine-development (accessed 30 March 2020)."},{"key":"bibr7-1470320320926902","unstructured":"ir.inovio.com\/news-releases\/news-releases-details\/2020\/Inovio-Selected-by-CEPI-to-Develop-Vaccine-Against-New-Coronavirus"},{"key":"bibr8-1470320320926902","unstructured":"Sanofi. Sanofi joins forces with U.S. Department of Health and Human Services to advance a novel coronavirus vaccine, https:\/\/www.sanofi.com\/en\/media-room\/press-releases\/2020\/2020-02-18-16-00-00 (accessed 30 March 2020)."},{"key":"bibr9-1470320320926902","unstructured":"Novavax. Novavax advances development of novel COVID-19 vaccine, http:\/\/ir.novavax.com\/news-releases\/news-release-details\/novavax-advances-development-novel-covid-19-vaccine (accessed 30 March 2020)."},{"key":"bibr10-1470320320926902","unstructured":"Novavax. Novavax awarded funding from CEPI for COVID-19 vaccine development, https:\/\/ir.novavax.com\/news-releases\/news-release-details\/novavax-awarded-funding-cepi-covid-19-vaccine-development (accessed 30 March 2020)."},{"key":"bibr11-1470320320926902","unstructured":"National Institutes of Health. NIH clinical trial of investigational vaccine for COVID-19 begins, https:\/\/www.nih.gov\/news-events\/news-releases\/nih-clinical-trial-investigational-vaccine-covid-19-begins (accessed 30 March 2020)."},{"key":"bibr12-1470320320926902","unstructured":"European Medicines Agency. https:\/\/www.ema.europa.eu\/en (accessed 30 March 2020)."},{"key":"bibr13-1470320320926902","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwaa036."}],"container-title":["Journal of the Renin-Angiotensin-Aldosterone System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1470320320926902","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1470320320926902","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1470320320926902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:39:56Z","timestamp":1777509596000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1470320320926902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1177\/1470320320926902"],"URL":"https:\/\/doi.org\/10.1177\/1470320320926902","relation":{},"ISSN":["1470-3203","1752-8976"],"issn-type":[{"value":"1470-3203","type":"print"},{"value":"1752-8976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4]]},"article-number":"1470320320926902"}}